Published • loading... • Updated
NHS in talks to roll out Alzheimer’s drug
The pTau217 test can identify Alzheimer’s pathology in 18 minutes and is expected to reach clinicians in six to nine months, researchers said.
- On Thursday, Health Minister Mark Butler will launch the Asia-Pacific Centre of Excellence for Alzheimer's Diagnosis in Sydney, following the Therapeutic Goods Administration's approval of the pTau217 blood test for clinical use.
- Unlike the previously approved pTau181 'rule-out' test, the new pTau217 assay functions as both a 'rule-out' and 'rule-in' test, achieving about 90 per cent diagnostic accuracy.
- Processing samples in 18 minutes, the new diagnostic tool offers a viable alternative to invasive lumbar punctures or expensive PET scans currently used for confirming pathology.
- NeuRA CEO Professor Matthew Kiernan stated the centre will generate reference data required for a Pharmaceutical Benefits Scheme listing, enabling doctors across Australia to order the test within six to nine months.
- Because protein changes occur 30 years before symptoms develop, early detection allows clinicians to intervene with disease-modifying therapies before significant neuronal death occurs in Alzheimer disease.
Insights by Ground AI
17 Articles
17 Articles
Yohanan: FDA approved an Alzheimer’s treatment, but 1 million Americans can’t get it
Some 79% of voters — including 78% of independents — support better access to coverage for Alzheimer’s detection and treatment. That’s according to a poll released in May. Some 89% say coverage restrictions from Medicare and private insurers are blocking…
Sydney Morning Herald+2 Reposted by 2 other sources
Alzheimer’s blood test to give Australians invaluable gift of time
While some facilities in Australia are already using the blood test for research, she said this is the first time it will be available clinically, with results delivered in just 18 minutes.
·North Sydney, Australia
Read Full Article
The British health service NHS has started negotiations to provide the first drugs that have been proven to slow the progression of Alzheimer's disease.
Coverage Details
Total News Sources17
Leaning Left6Leaning Right2Center4Last UpdatedBias Distribution50% Left
Bias Distribution
- 50% of the sources lean Left
50% Left
L 50%
C 33%
R 17%
Factuality
To view factuality data please Upgrade to Premium
